Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.75
-0.36 (-2.38%)
At close: Jul 17, 2026, 4:00 PM EDT
14.69
-0.06 (-0.41%)
After-hours: Jul 17, 2026, 4:24 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $490.13 million as of July 17, 2026. Its market cap has increased by 90.80% in one year.
Market Cap
490.13M
Enterprise Value
302.51M
1-Year Change
90.80%
Ranking
Category
Stock Price
$14.75
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $490.13M, an increase of 58.73%. That is a compound annual growth rate of 53.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 490.13M | 111.39% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 541.54M |
| Eikon Therapeutics | 538.68M |
| Contineum Therapeutics | 523.78M |
| Arvinas | 518.11M |
| Silence Therapeutics | 515.79M |
| Assembly Biosciences | 512.08M |
| Verastem | 507.03M |
| Zura Bio | 498.74M |